People with two specific genetic variants in the USF1 gene show a stronger reduction in fat release from fat cells when insulin is present, and their bodies respond more effectively to insulin in...
Mechanism
Synthesis from 1 study
These gene versions make insulin better at telling fat cells to stop releasing fatty acids after eating sugar, which lowers fat levels in the blood. A different gene combo in the same people can cause fat to build up in the liver, but that’s a separate effect and doesn’t explain why fat release...
Most probable mechanism
People with these specific gene versions have a stronger signal from insulin that tells fat cells to stop releasing fatty acids into the blood after eating sugar. This happens because the gene changes make a protein that better controls the enzyme responsible for breaking down fat, so less fat gets released when insulin is present.
USF1 transcription factor binds to promoter regions of the hormone-sensitive lipase (HSL) gene in adipocytes and regulates its expression.
The usf1s1 T allele and usf1s2 A allele alter USF1 function or expression, increasing its transcriptional activity in adipocytes.
Enhanced USF1 activity leads to greater insulin-mediated suppression of HSL activation in adipose tissue, reducing the breakdown of triglycerides into free fatty acids.
Reduced lipolysis results in lower circulating free fatty acid levels during insulin stimulation, as measured during oral glucose tolerance tests and euglycemic hyperinsulinemic clamps.
Less supported by current evidence, but not ruled out
In some people, these gene versions combine with another gene change that reduces the liver's ability to clear fat from the blood, leading to more fat building up in the liver — but this does not explain the improved suppression of fatty acids in the blood after eating sugar.
USF1 regulates expression of hepatic lipase (LIPC) in the liver, which breaks down triglycerides in circulating lipoproteins.
The LIPC −514C>T SNP reduces hepatic lipase activity, decreasing triglyceride clearance from the bloodstream.
Homozygosity for major USF1 alleles combined with the LIPC −514T allele leads to reduced triglyceride clearance and increased hepatic uptake of fatty acids.
This results in elevated liver fat content, independent of the antilipolytic insulin sensitivity observed in adipose tissue.
Evidence from Studies
Supporting (1)
Community contributions welcome
Contradicting (0)
Community contributions welcome
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.